A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Triple Negative Breast Cancer|Gastric Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: navicixizumab+paclitaxel|BIOLOGICAL: navicixizumab+irinotecan|BIOLOGICAL: navicixizumab monotherapy
Sponsor: OncXerna Theraputics, Inc.